arrow
S

Susanne Brandstetter

University of Regensburg
H指数:34
被引数:4,374

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Which healthcare services did children and adolescents use before presentation at specialised outpatient clinics for post-COVID-19 condition? Descriptive findings from the Post-COVID Kids Bavaria study

“后COVID-19条件下,儿童和青少年在就诊于专业门诊前使用了哪些医疗保健服务?——来自Post-COVID Kids Bavaria研究的描述性发现”

2026-04-100
PRE
How can midwives in Germany be supported in advising on early childhood allergy prevention in a health literacy-responsive way? Protocol for a mixed-methods study to co-design and evaluate an educational intervention following the Medical Research Council framework

如何支持德国助产士以健康素养响应的方式就早期儿童过敏预防提供建议?一项遵循英国医学研究理事会框架,通过混合方法研究共同设计和评估教育干预措施的方案

2025-12-100
OA
Complementary Predictors for Asthma Attack Prediction in Children: Salivary Microbiome, Serum Inflammatory Mediators, and Past Attack History

哮喘发作预测的补充预测因子:唾液微生物组、血清炎症介质和既往发作史

2025-08-180
OAAI
Metabotypes are linked to uncontrolled childhood asthma, gut microbiota, and systemic inflammation

代谢表型与未控制儿童哮喘、肠道微生物群和系统性炎症相关。

2025-04-230
OAAI
Epigenome-Wide Association Study of Asthma Exacerbations in Europeans

哮喘急性加重在欧洲人群中的全基因组甲基化关联研究

2025-02-050
PRE
Association of Corticosteroid Inhaler Type with Saliva Microbiome in Moderate-to-Severe Pediatric Asthma
2025-01-020
OAAI
Exhaled Volatile Organic Compounds for Asthma Control Classification in Children with Moderate to Severe Asthma Results from the SysPharmPediA Study

呼出挥发性有机化合物用于中度至重度哮喘儿童的哮喘控制分类来自SysPharmPediA研究的结果

2024-11-013
PRE
Salivary microbiome as a prognostic biomarker for asthma attacks in children: results from a machine-learning approach in the SysPharmPediA study
2024-10-300
PRE
Ethnic disparities in asthma burden and gut bacteriome profiles of children with moderate-to-severe asthma in Europe
2024-10-300
PRE
Association of corticosteroid inhaler type with saliva microbiome in moderate-to-severe pediatric asthma
2024-10-300
PRE
Association of blood inflammatory endotypes and asthma burden in moderate-to-severe pediatric asthma
2024-10-300
PRE